Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis-Reference-Cited by-同舟云学术

Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis

Published:2021-10 Issue: Volume:96 Page:103247
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Amoako Afia,Ortiz-Paredes David,Engler Kim,Lebouché Bertrand,Klein Marina B.

Funder

Gilead Sciences Inc

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference35 articles.

1. Integration of Hepatitis C Treatment in a Primary care Federally Qualified Health Center; Philadelphia, Pennsylvania, 2015-2017;Bartholomew;Infectious Diseases,2019

2. Making sense of “side effects”: Counterpublic health in the era of direct-acting antivirals;Bryant;International Journal of Drug Policy,2019

3. Reducing patient and provider knowledge gaps: An evaluation of a community informed hepatitis C online course;Buller-Taylor;Patient Education and Counseling,2018

4. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs;Childs;Harm Reduction Journal,2019

5. Pathways to ensure universal and affordable access to hepatitis C treatment;Douglass;BMC Medicine,2018

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model;PLOS ONE;2024-08-29

2. Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs;Harm Reduction Journal;2024-08-28

3. Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study;Harm Reduction Journal;2024-07-25

4. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study;International Journal of Drug Policy;2024-07

5. The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation;Journal of General Internal Medicine;2024-05-23